<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04189198</url>
  </required_header>
  <id_info>
    <org_study_id>Articaine versus bupivacain</org_study_id>
    <nct_id>NCT04189198</nct_id>
  </id_info>
  <brief_title>A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block</brief_title>
  <official_title>A Randomized Controlled Trial : Comparison of 4% Articaine Versus 0.5% Bupivacaine for Ambulatory Orthopaedic Surgery Under Supraclavicular Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper
      limb
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator aim to compare Articaine 2% versus bupivacaine 0.5% in patient undergoing
      upper limb procedure under ultrasound guided supraclavicular block as regard onset and
      duration of sensory and motor block
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 30, 2019</start_date>
  <completion_date type="Actual">March 27, 2020</completion_date>
  <primary_completion_date type="Actual">March 22, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of sensory block</measure>
    <time_frame>Measured in minutes over 24 hours</time_frame>
    <description>By pinprick test from 0 to 2 where 0 no sensory block and 2 complete anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Durations of motor block</measure>
    <time_frame>Measured in minutes over 24 hours</time_frame>
    <description>By Bromage scale from 1 to 4 where 1 no motor power and 4 full motor power</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>Measured in minutes over 24 hours</time_frame>
    <description>Measured by numerical analog scale where 0 no pain and 10 means worst pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>First analgesia required</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Upper Limb Surgery</condition>
  <condition>Hand Surgery</condition>
  <arm_group>
    <arm_group_label>Articaine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group are assigned to recieve 30 ml of Articaine 2%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group are assigned to recieve 30 ml of bupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Articaine</intervention_name>
    <description>Supraclavicular block with 30 ml articaine 2%</description>
    <arm_group_label>Articaine group</arm_group_label>
    <other_name>Artinebsa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Supraclavicular block with 30 ml bupivacaine 0.5%</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  upper limb surgery

          -  ganglion removal

          -  k wiring

          -  Carapal tunnel

        Exclusion Criteria:

          -  Coagulopathy.

          -  infection at site of injection.

          -  patient refusal.

          -  hypersensitivity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Galal Mo El kadi, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain Shams University hosptal</name>
      <address>
        <city>Cairo</city>
        <state>Abbasya</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2019</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>simon Halim Armanious</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Articaine</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Supraclavicular block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data including primary and secondary outcome for all the participants</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Within 6 month after end of study</ipd_time_frame>
    <ipd_access_criteria>Upon request from Corresponding Author</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

